Introduction
Cardiovasc ular diseases ( CVD) or diseases of the c irc ulatory system represent various c linic al c onditions due to atherosc lerotic impairment of c oronary, c erebral or peripheral arteries. The Americ an Heart Assoc iation uses the ICD 1 0 c odes I0 0 -I9 9 inc luding diseases of veins and lymphatic s. CVD are c onsidered nowadays as the major c auses of death in developed c ountries for men and women. Detailed epidemiologic al data for CVD are available from the Americ an Heart Assoc iation's "2 0 0 2 Heart and Statistic al Update" summarizing the risk fac tors. From these data it was c alc ulated that 1 in 5 c itizens have some form of CVD. Comparison of the death rates of various c ountries ( Table 2 ) shows that there is a relationship between soc io-ec onomic situations and a kind of east-west and north-south dec line [ 2 2 ] For the follow-up, diagnosis and risk stratific ation of patients the diagnostic laboratory in c ombination with radiology tec hniques plays a major role. The aim of this review is to desc ribe the diagnostic usefulness of established and new analytes related to c ardiac func tion, c oagulation, endothelial dysfunc tion and risk fac tors. Some of the strategies mentioned are based on experimental bioc hemic al findings.
Markers for cardiac function

Acute myocardial infarction
Sinc e 1 9 9 0 several new markers have been introduc ed in the diagnostic laboratory for ac ute myoc ardial infarc tion ( MI) . These analytes are spec ific c ardiac proteins exhibiting a better diagnostic validity than ac tivity of total CK l and CK-MB previously used. There is now c onsensus among IFCC experts that the most rational way to diagnose MI is the use of a so-c alled "early" and a "late" marker released from c ardiac myoc ytes under isc haemic c onditions. Myoglobin is c onsidered the optimal "early" marker starting to rise 2 to 3 hours and peaking 8 to 1 2 hours after onset of the c linic al symptoms. Normal c onc entrations are reac hed again after 2 4 hours. The c ardiac troponins peak at 1 2 to 4 8 hours, and remain elevated for 4 to 1 0 days. Ac c ording IFCC guidelines, spec imen
Cardiovascular disease
Number of patients All 61,800,000 High blood pressure 50,000,000
Coronary heart disease Myocardial infarction Angina pectoris 12,600,000 7,500,000 6,400,000 Stroke 4,600,000 Congenital heart failure 1,000,000 Congestive heart failure 4,790,000 Figure 1 [ 1 ] a typic al time-c ourse in a patient with MI is shown. Ac c ording to the diagnostic validities published for CK total, CK-MB, the troponins and myoglobin ( Table 3 ) [ 2 ] it is antic ipated that after the present transition period c linic ians will ac c ept in the future myoglobin and troponin measurements as the gold standards for the diagnosis of MI.
With regard to unstable angina the IFCC and the National Ac ademy of Clinic al Chemistry ( NACB) have stated that patients with small inc reases of troponin ( the 9 7 .5 th perc entile of the normal healthy population) should be used as the c ut-off point for risk-stratific ation and further angiographic examinations.
Ventricular dysfunction
For more than 1 0 years a lot of researc h foc used on the func tion of the natriuretic peptides whic h affec t systemic blood pressure by several mec hanisms, inc luding modific ation of renal func tion and vasc ular tone, c ounterac ting of the renin-angiotensin-aldosterone system and ac tion on brain regulatory sites. These systems maintain a balanc e that ensures relative c onstanc y of body elec trolyte and water c ontent and c irc ulatory homeostasis. The natriuretic peptides ( BNP and ANP) investigated sinc e more than 1 0 years are potential diagnostic tools in the assessment of patients' ventric ular func tion.
Brain natriuretic peptide ( BNP) , also known as ventric ular natriuretic peptide, is a c ardiac hormone sec reted predominantly from the ventric le. Its biologic ally ac tive, low molec ular form with 3 2 amino ac ids ( BNP-3 2 , proBNP ( 7 7 -1 0 8 ) , half-life time: 2 0 min) with vasodilator and natriuretic properties, is c leaved from the proBNP, stored in human c ardiac tissue and released from the c ardiac ventric les in response to stretc hing of the c hamber. The sec ond remnant after c leavage, N-terminal proBNP ( NT-proBNP, proBNP ( 1 -7 6 ) , half-life time: 6 0 -1 2 0 min) , is a 7 6 amino ac id peptide with no known biologic al func tion. Plasma levels of NT-proBNP and BNP-3 2 are similar in normal subjec ts. In NYHA Class I, II and III subjec ts, the levels of NT-proBNP are 4 -fold higher than c onc omitant BNP-3 2 levels. It was shown, that left ventric ular ejec tion frac tion ( LVEF) , exerc ise-test time and c reatinine c learanc e were independent predic tors of NTproBNP plasma c onc entrations. The levels of NT-proBNP and BNP-3 2 were highly c orrelated. Nevertheless, sinc e the inc rement above normal levels of NT-proBNP exc eeds that for BNP-3 2 in c ardiac impairment it is now agreed that NT-proBNP is a more useful marker of early c ardiac dysfunc tion than BNP-3 2 and may represent c ardiac status over longer periods [ 3 ] .
NT-proBNP seems to be helpful in the diagnosis of heart failure in the overall population. NT-proBNP is reported to be a very useful tool [ 4 ] espec ially for the detec tion of left ventric ular systolic dysfunc tion. The diagnostic validities for NT-proBNP in the general population, in patients with existing heart failures and with risks for heart failure are shown in Table 4 [ 5 ] . Bec ause of its high negative predic tive values patients with a positive result should be sent to the c linic ians for c ardiac imaging. Distinguishing dyspnoea due to c ongestive heart failure is also disc ussed as a potential applic ation of BNP measurements [ 6 ] .
The atrial natriuretic peptides ( ANP) exhibit similar physiologic al func tions than BNP. ProANP ( 1 -1 2 6 ) is stored in membrane-bound granules in artrial c ardioc ytes. Upon stimulation, these granules move to the c ell surfac e, releasing the stored proANP ( half-life time 6 0 min) . This prohormone is c leaved into the ac tive 2 8 amino ac id peptide ANP ( pro ANP ( 9 9 -1 2 6 ) , a-ANP, half-life time: 2 .5 min) , and an Nterminal ANP fragment ( NT-proANP, proANP ( 1 -9 8 ) whic h is further proc essed within the c irc ulation to form proANP ( 1 -3 0 ) , proANP ( 3 1 -6 7 ) and proANP ( 7 9 -9 8 ) . Due to muc h longer biologic al half proANP moieties exhibit up to 5 0 times higher plasma c onc entration than a-ANP.
Several studies reported that plasma-levels of a-ANP and NTproANP were signific antly elevated even in asymptomatic patients with left ventric ular dysfunc tion. A c omparison of the new c ardiac markers NT-proANP, BNP and NT-proBNP demonstrate the effic ienc y for diagnosis of patients with impaired left ventric ular ejec tion frac tion ( LVEF) ( Table 5 , Fig. 2 ) [ 7 , 8 ] .
This c linic al study shows on basis of the ROC c urves that NTproANP might be the most useful non-invasive marker. Based on the c linic al investigations, measurement of natriuretic peptides is useful for those c linic al c onditions summarized in Table 6 . Even in c linic ally asymptomatic patients the peptides were reported to be of value. Referenc e: Maeda K. et al. [ 7 ] 
Markers for thrombophilia
Thrombophilia c an be defined as an inc reased tendenc y for venous and arterial thrombo-embolic events. Thrombophilia oc c urs from very different bioc hemic al, genetic and immunologic al abnormalities and is induc ed by mec hanic al or rheologic al adverse events. Thromboembolic episodes due to plasmatic hyperc oagulation and hypofibrinolysis are often assoc iated with surgery, immobilization, autoimmune disease, impaired gluc ose toleranc e or type 2 diabetes mellitus resulting in reduc ed endothelial thrombotic resistanc e and hyper-reac tivity of thromboc ytes. The various c onditions assoc iated with thromboembolic events are summarized in Table 7 .
Defining the c ause of hyperc oagulability may determine the type and duration of treatment for the assoc iated thromboembolic events. In addition, finding a genetic defec t in c oagulation allows for testing at least the firstdegree asymptomatic family members.
A: LVEF < 48 % based on 3D-echocardiography and < 55 % based on RNV B: Resting LVEF < 40 % based on RNV. Table 6 . Natriuretic peptides in heart function assessment
Monitoring of ACE-inhibitors therapy
Rational screening
Several c linic al investigations have been c onduc ted to determine the prevalenc e of the various c oagulation fac tor defec ts in the general population. All these c hanges in the plasmatic c oagulation lead to a several fold inc rease in the risk for developing thromboembolic events. In Table 8 [ 9 , 1 0 , 1 1 ] the c linic al knowledge gathered so far is summarized. It is obvious that the risk for thrombosis in families showing one or even more defec ts is usually 4 -to 8 -fold higher c ompared to the general population.
Based on these fac ts and figures the diagnostic laboratory is requested to perform a kind of rationale step-by-step diagnosis in patients with c linic al symptoms and or a family history of thromboembolic diseases ( deep venous thrombosis, stroke, pulmonary embolism) . Investigation of a patient always starts with the global ( routine) c oagulation tests, followed by sc reening for the protein C pathway ( Figure 3 ) and homoc ysteine plasma levels, finally ending-up with the determination of the single c oagulation fac tors and antiphospholipid antibodies. Usually a prolonged ac tivated prothrombin time due to c onsumption of c oagulation fac tors or defic ienc ies is one of the first hints of a disturbanc e. It is stressed that hyperc oagulability disorders c an be diagnosed in approximately 8 0 % of patients suffering from thrombotic events.
Markers of endothelial function
Over the last twenty years, researc hers have found an extraordinary variety of endothelial func tions, inc luding c ontrol over c oagulation, fibrinolysis, vasc ular tone and growth as well as immune responses [ 1 2 ] . With regard to its c entral loc ation, its integrating and transduc ing c apability, and the large repertoire of its biologic ally ac tive produc ts, the endothelium plays a main role in a series of pathophysiologic al balanc es ( Figure 4 ) . It is well ac c epted that the repeated injury or lac k of the endothelium is responsible for loc al ac tivation of platelets, ac tivation of c oagulation and release of growth fac tors whic h lead to intimal hyperplasia, lipid ac c umulation and formation of atherosc lerotic lesions. The well-known c onsequenc es of theses lesions are the development of c ardiovasc ular diseases.
2 .4 .Endothelium and c oagulation
In an antagonistic manner dependent on the environment the endothelial monolayer influenc es platelet func tion, plasmatic c oagulation and fibrinolysis by a variety of antiand proc oagulant produc ts and metabolites released being normally in a balanc e ( ) and endothelium derived relaxing fac tor ( EDRF) and by inhibition of plasmatic c oagulation. However, when the endothelium is perturbed by physiologic al forc es or by spec ific c hemic al fac tors, the c ells undergo programmatic bioc hemic al c hanges that c ulminate in their transformation to a prothrombotic surfac e ( Table 9 ) .
Fac tor VIII-vWF as well as thrombomodulin c an serve as a marker of endothelial dysfunc tion in several diseases demonstrating probably imbalanc e. For example in patients suffering from peripheral vasc ular disease signific antly elevated plasma levels in c omparison to healthy c ontrols are reported ( Table 1 0 ) [ 1 3 ] . In patients with a peripheral arterial oc c lusive disease thrombomodulin measured at entry is reported to be signific antly higher in those patients developing late restenosis [ 1 4 ] . From these results inc reased plasma thrombomodulin levels seem to be a hint for hyperc oagulability.
Endothelium and vascular tone
Endothelial c ells sec rete mediators that influenc e the vasc ular tonus and hemodynamic s ( Table 1 1 ) [ 1 2 ] . The switc h from a normally predominant release of relaxing fac tors to that of c ontrac ting fac tors is suggested to play a key role in atherosc lerosis. Release of NO from endothelial c ells is enhanc ed by physic al and c hemic al stimuli suc h as pulsatile blood flow, hypoxia, free radic als, ac etylc holine, thrombin, serotonin, histamine, substanc e P and bradykinin [ 1 2 ] . NO ac ts as a kind of anti-vasoc onstric tor to stimuli suc h as free radic als during oxidative stress and inflammation responsible for release of endothelin I and ACE, the most potent to vasoc onstric tors. The latter are inc reased under various c linic al c onditions and most probably triggered by immunologic al and inflammatory stimuli; inc reased blood levels of ET-1 are seen in patients with c ongestive heart failure ( CHF) and after heart transplantation [ 1 5 ] The systemic hypotension observed in septic patients is related to an inc rease in NO produc tion. The imbalanc e of the vasc ular tonus by exc essive endothelin I and NO produc tions due to endothelial dysfunc tion is c learly demonstrated in patients suffering from bac terial septic infec tions ( Figure 5 ) 
Endothelium and immune response
Vasc ular endothelial c ells play an important part in c ombination with blood c ells during the ac tivation of the immune system. There exists a c omplex system: c ytokines exc reted from lymphoc ytes and monoc ytes stimulate endothelial c ells to release c ytokines too, eic osanoids, and adhesion molec ules. The up-regulation and expression of adhesion molec ules result in c hemo attrac tion of mononuc lear c ells and fac ilitate their penetration through the endothelial monolayer to the intimae, a proc ess important for parthenogenesis ( 1 2 ) . Marked inc reases in c irc ulating levels of adhesion molec ules were observed in hyperlipidaemia, hypertension, diabetes mellitus, under oxidative stress, and c igarette smoking ( 1 2 ,1 8 ,1 9 ) . Inc reased plasma levels of the adhesion molec ule P-selec tin in patients with hypertension demonstrate the progressive vasc ular damage due to inc reased sheer stress ( Figure 6 ) ( 1 9 ) and most probably c onc omitant with adhesion of leukoc ytes on the endothelial surfac e.
The physiologic al func tion of the endothelium is rather c omplex and the various func tions desc ribed oc c ur simultaneously in order to keep a homeostatic c ondition. Several molec ules mentioned as markers of ac ute and c hronic endothelial ac tivation with subsequent dysfunc tion of the endothelium are c onsidered to play a role in atherosc lerosis. They may furthermore serve as a tool to monitor the impac t of prevention and intervention on vasc ular damage.
Risk factors
Oxidative stress as a result of the enhanc ed formation of reac tive oxygen spec ies ( ROS) due to infec tions or immune response plays a c entral role in the pathogenesis of arteriosc lerosis assoc iated diseases. Hyperc holesterolaemia, hyperlipidaemia, hypertension, c igarette smoking, diabetes mellitus, and the c hronic ac tivation of the immune system are c lassic al c onditions where enhanc ed ROS c onc entrations are observed. The measurements of thiobarbituric ac id reac tive substanc es ( TBARS) are serving sinc e several years as measure for these pathologic al c onditions, sinc e oxidative spec ies are essential for the modific ation of lipoproteins and their atherogenic effec ts. In diabetic s with peripheral vasc ular diseases and/or c oronary artery diseases plasma TBARS were signific antly elevated ( Table 1 2 ) ( 2 0 ) . Their inc rease was more pronounc ed than the lipids investigated and c orrelated with the patients' c linic al c onditions.
Conclusion
It was the aim of this review to highlight established markers of c ardiovasc ular diseases used for the diagnosis of myoc ardial infarc tion and for the diagnosis of thromboembolic events. In addition some new molec ules were desc ribed as potential new markers of dysfunc tion of the endothelium and thus being relevant for atherogenesis. 
Inhibitor of coagulation Promoters of coagulation
Marker Controls Patients
Factor VIII von Willebrand (U/L) 1020 ± 300 1330 ± 340 * Thrombomodulin (ng/ml) 46 ± 14 55 ± 15 ** Referenc e: Verhaar MC et al [ 1 9 ] For many of them, however, the mec hanisms underlying the genesis of c irc ulating forms, as well as their pathophysiologic al signific anc e, remain unc lear so far. Further studies are nec essary to establish the diagnostic relevanc e of these serum markers of endothelial func tion in large sc ale c linic al investigations. They may be additional tools in the risk stratific ation of c ardiovasc ular diseases.
Recommended literature:
